• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. A UNCONTROLLED RANDOMISED TRIAL ON EVALUATION OF SAFETY AND EFFICACY OF INTRALESIONAL VITAMIN D3 IN CUTANEOUS WARTS

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

A UNCONTROLLED RANDOMISED TRIAL ON EVALUATION OF SAFETY AND EFFICACY OF INTRALESIONAL VITAMIN D3 IN CUTANEOUS WARTS

    Author

    • Dr. Anamita Khan Mandal Dr. Arpita Agrawal Dr. Rahul Tripathi
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Introduction: Cutaneous warts are treated primarily with destructive methods such as topical keratolytics, electrocoagulation, cryotherapy or laser therapy or electrocautery. These modalities of treatment are time-consuming and may be associated with scarring in multiple warts. Immunotherapy is emerging as a new modality of treatment which acts on enhancing cell-mediated immunity against human papillomavirus for clearance of both treated and distant warts.
Aim and Objective of the study: The aim of our study is to evaluate the safety and efficacy of intralesional vitamin D3 in the treatment of cutaneous warts.
Materials and Methods: Larger warts were considered for the injection. A maximum of 2 warts were treated at each session. The injections were repeated at 2 weekly intervals for a maximum of four injections. If complete clearance was achieved before four injections, the treatment was stopped, and patient was followed up for recurrence. Patients were evaluated for treatment efficacy and adverse reactions every 2 weeks for first 2 months and monthly thereafter to record for any recurrence for 6 months.
Results: In the present study, 27 patients had palmoplantar warts, out of which 19 (70%) had complete clearance, 6 (22.2%) had moderate clearance and 2 (7.4%) patients had mild clearance. 22 patients had verruca vulgaris, out of which 15 (68.18) had complete clearance, 5 (22.7%) had moderate clearance and 2 (9.09%) had mild clearance. Only 2 patients had filiform wart, out of which 1 (50%) had moderate clearance and 1 (50%) had mild clearance. 
Discussion and conclusion: Intralesional Vitamin D3 injection is a novel approach for the treatment of warts. It is inexpensive, safe and special value to treat multiple warts in developing countries. Our study showed good response to the treatment in subjects suffering from cutaneous warts.

Keywords

  • palmoplantar warts
  • verruca vulgaris
  • vitamin D3
  • immunotherapy and cutaneous warts
  • XML
  • PDF 577.41 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 24
    • PDF Download: 80
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 7
September 2022
Page 3265-3271
Files
  • XML
  • PDF 577.41 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 24
  • PDF Download: 80

APA

Dr. Rahul Tripathi, D. A. K. M. . D. A. A. (2022). A UNCONTROLLED RANDOMISED TRIAL ON EVALUATION OF SAFETY AND EFFICACY OF INTRALESIONAL VITAMIN D3 IN CUTANEOUS WARTS. European Journal of Molecular & Clinical Medicine, 9(7), 3265-3271.

MLA

Dr. Anamita Khan Mandal Dr. Arpita Agrawal Dr. Rahul Tripathi. "A UNCONTROLLED RANDOMISED TRIAL ON EVALUATION OF SAFETY AND EFFICACY OF INTRALESIONAL VITAMIN D3 IN CUTANEOUS WARTS". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 3265-3271.

HARVARD

Dr. Rahul Tripathi, D. A. K. M. . D. A. A. (2022). 'A UNCONTROLLED RANDOMISED TRIAL ON EVALUATION OF SAFETY AND EFFICACY OF INTRALESIONAL VITAMIN D3 IN CUTANEOUS WARTS', European Journal of Molecular & Clinical Medicine, 9(7), pp. 3265-3271.

VANCOUVER

Dr. Rahul Tripathi, D. A. K. M. . D. A. A. A UNCONTROLLED RANDOMISED TRIAL ON EVALUATION OF SAFETY AND EFFICACY OF INTRALESIONAL VITAMIN D3 IN CUTANEOUS WARTS. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 3265-3271.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus